Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06219213
NA

Glyceryl Eicosapentaenoate Based Topic Products As an Irritant-free Cream and Serum for Hydration of Sensitive Skin

Sponsor: SCF Pharma

View on ClinicalTrials.gov

Summary

This exploratory study aims to verify the hydrating potential as well as the possible irritant effects of a 14-day hydrating treatment consisting of daily application of serum and cream to the skin of two dry targeted areas. Thirty-three (33) subjects will be enrolled in this study and will be divided into three different treatment groups of 11 subjects each. Apart from the formulation of the cream which varies between the three groups, the subjects will receive the same serum and adhere to the same study plan for fourteen days. Each subject's baseline condition before treatment will serve as a control for effects observed after treatment on targeted areas.

Official title: Impact of a Daily Application of Serum and Cream Containing Glyceryl Eicosapentaenoate and Short-chain Fatty Acids on Skin Hydration: Exploratory Study (COS-PBP-01)

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

33

Start Date

2023-07-25

Completion Date

2025-08-07

Last Updated

2024-12-03

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

Glyceryl Eicosapentaenoate serum

Daily application of serum on both targeted skin areas for 14 consecutive days. Serum must be applied before the Cream on clean skin.

OTHER

Glyceryl Eicosapentaenoate Cream A

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

OTHER

Glyceryl Eicosapentaenoate Cream B

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

OTHER

Glyceryl Eicosapentaenoate Cream C

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

Locations (1)

Institut de recherche clinique du littoral (IRCL)

Rimouski, Quebec, Canada